- Home
- TACH vs FENC Comparison
TACH vs FENC Comparison
Compare TACH & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$12.34
Company Overview
Basic Information| Metric | TACH | FENC |
|---|---|---|
| Founded | 2024 | 1996 |
| Country | United States | United States |
| Employees | N/A | 35 |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.1M | 430.3M |
| IPO Year | 2025 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TACH | FENC |
|---|---|---|
| Price | $10.48 | $12.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 24.3K | ★ 201.5K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | ★ $39.02 | $196.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.10 | $5.65 |
| 52 Week High | $10.59 | $13.25 |
Technical Indicators
Market Signals| Indicator | TACH | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 59.37 |
| Support Level | $10.27 | $9.74 |
| Resistance Level | $10.51 | N/A |
| Average True Range (ATR) | 0.01 | 0.69 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 46.15 | 52.53 |
Price Performance
Historical Comparison TACH
FENC
About TACH Titan Acquisition Corp. Class A Ordinary Shares
Titan Acquisition Corp is a blank check company.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.